Mizuho Securities USA LLC Raises Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Mizuho Securities USA LLC lifted its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 807.3% during the third quarter, HoldingsChannel.com reports. The fund owned 14,970 shares of the medical instruments supplier’s stock after purchasing an additional 13,320 shares during the quarter. Mizuho Securities USA LLC’s holdings in Mettler-Toledo International were worth $22,451,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. PineStone Asset Management Inc. raised its stake in Mettler-Toledo International by 127.4% during the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after acquiring an additional 145,453 shares during the last quarter. Capital International Investors increased its holdings in shares of Mettler-Toledo International by 15.1% in the first quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock valued at $1,431,696,000 after purchasing an additional 141,431 shares during the period. International Assets Investment Management LLC raised its stake in shares of Mettler-Toledo International by 149,870.0% during the third quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock worth $134,946,000 after purchasing an additional 89,922 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Mettler-Toledo International by 88.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 122,655 shares of the medical instruments supplier’s stock worth $163,290,000 after purchasing an additional 57,509 shares during the period. Finally, Massachusetts Financial Services Co. MA grew its position in Mettler-Toledo International by 32.5% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock valued at $199,777,000 after buying an additional 35,048 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Elisha W. Finney sold 76 shares of the stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now directly owns 240 shares in the company, valued at $314,820. This represents a 24.05 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Stock Down 4.7 %

Shares of NYSE:MTD opened at $1,179.58 on Friday. The company has a market capitalization of $24.89 billion, a P/E ratio of 31.80, a P/E/G ratio of 4.16 and a beta of 1.16. Mettler-Toledo International Inc. has a 52-week low of $1,041.49 and a 52-week high of $1,546.93. The stock’s fifty day simple moving average is $1,382.02 and its 200-day simple moving average is $1,400.14.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The company had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. On average, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 40.37 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on MTD shares. JPMorgan Chase & Co. increased their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a report on Monday, August 5th. Stifel Nicolaus dropped their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Robert W. Baird reduced their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Evercore ISI upped their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Finally, Wells Fargo & Company reduced their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International has a consensus rating of “Hold” and a consensus target price of $1,338.75.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.